Repligen Corp
RGEN· Nasdaq
RGENRepligen Corp
Filed Feb 17, 2022 · 10-K · 48 days after period end · 0000950170-22-001430
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $186.52M | $108.65M | $69.47M | $51.94M |
| Net Income | $29.11M | $19.70M | $3.60M | $5.64M |
| EPS Diluted | — | $0.36 | $0.07 | $0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Repligen Corp · CIK 730272 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Feb 17, 2022 · 48 d after period end
